Formula Grant 03J09401
- The U.S. Environmental Protection Agency (EPA) has awarded a $17,610,000 Formula Grant under the Drinking Water State Revolving Fund (CFDA 66.468) program to the Washington State Department of Health. The purpose of this grant is to capitalize the state's Drinking Water State Revolving Fund to address emerging contaminants in drinking water, with a focus on projects targeting per- and polyfluoroalkyl substances (PFAS). The funding will enable the state to provide low-interest loans to public...
- This federal Formula Grant award, provided by the Environmental Protection Agency (EPA) under the Drinking Water State Revolving Fund (DWSRF) program (CFDA 66.468), grants $12,806,400.00 to the Washington State Department of Health to capitalize its DWSRF program. The funding will enable the department to offer low-interest financing to public water systems for planning, designing, and constructing eligible drinking water infrastructure projects that enhance public health protection, including...
- The Washington State Department of Health was awarded a $24.576 million capitalization grant through the Environmental Protection Agency's Drinking Water State Revolving Fund program. The grant period runs from July 1, 2021 through June 30, 2026. Funds will be used to provide low-interest financing to local entities for eligible drinking water infrastructure projects that protect human health. As the designated recipient of EPA Region 10's Drinking Water State Revolving Fund capitalization...
- The Environmental Protection Agency (EPA) awarded a $13,568,400 Drinking Water State Revolving Fund (CFDA 66.468) formula grant to the Washington State Department of Health. The grant will capitalize the state's DWSRF to provide low-interest financing for planning, design, and construction of eligible drinking water infrastructure projects. Funds can be used for activities like improving water treatment, distribution networks, water supply sources, and finished water storage to protect public...
- This $63,160,800 Drinking Water State Revolving Fund (CFDA 66.468) Formula Grant award from the U.S. Environmental Protection Agency (EPA) provides funding to the Washington State Department of Health to capitalize their Drinking Water State Revolving Fund program. The recipient will use these funds to offer low-interest financing to public water systems in Washington for planning, design, and construction of eligible drinking water infrastructure improvement projects. The grant also supports...
- This $35,899,000 Formula Grant award from the U.S. Environmental Protection Agency (EPA) under the Drinking Water State Revolving Fund (CFDA 66.468) program provides capitalization funding to the New York State Department of Health (NYSDOH) for its Drinking Water State Revolving Fund (DWSRF) program. The funding will support low-interest financing for DWSRF-eligible projects that address emerging contaminants, with a focus on perfluoroalkyl and polyfluoroalkyl substances (PFAS), in drinking...
- This is a Formula Grant award from the Environmental Protection Agency (EPA) under the Drinking Water State Revolving Fund (CFDA 66.468) program. The $36,775,000 grant provides capitalization funding for the New York State Department of Health's (NYSDOH) Drinking Water State Revolving Fund (DWSRF) program. The grant supports the planning, design, and construction of drinking water infrastructure projects that address emerging contaminants, with a focus on projects targeting per- and...
- This $3,698,000.00 U.S. Environmental Protection Agency (EPA) Clean Water State Revolving Fund (CFDA 66.458) formula grant will provide capitalization funding to the State of Washington, Department of Ecology, to establish and maintain a revolving loan fund for water quality improvement projects. The primary purpose is to address emerging contaminants, including substances from personal care products, pharmaceuticals, industrial chemicals, pesticides, and microplastics. The State will use...
- This $11,116,000 Formula Grant award from the U.S. Environmental Protection Agency's (EPA) Drinking Water State Revolving Fund (CFDA 66.468) provides capitalization funding to the Virginia State Board of Health Office of Emergency Preparedness to support their Drinking Water State Revolving Fund program. The funding will be used to offer low-interest financing for planning, design, and construction of eligible drinking water improvement projects, with a focus on addressing emerging...
- This federal Formula Grant award, provided by the U.S. Environmental Protection Agency (EPA) under the Clean Water State Revolving Fund (CFDA 66.458) program, provides $47,458,800.00 in funding to the State of Washington, Department of Ecology to capitalize their Clean Water State Revolving Fund program. This program enables the state to offer low-interest financing to numerous sub-recipients, including municipalities and utilities, for eligible water quality improvement and protection projects....
This $18,026,000 Formula Grant award from the U.S. Environmental Protection Agency (EPA), under the Drinking Water State Revolving Fund (CFDA 66.468) program, provides capitalization funding to the Washington State Department of Health (WA DOH) to support their Drinking Water State Revolving Fund (DWSRF) program. These funds will be used by WA DOH to offer low-interest financing to eligible public water systems in Washington for the planning, design, and construction of drinking water infrastructure projects that address emerging contaminants, with a focus on per- and polyfluoroalkyl substances (PFAS). Additionally, WA DOH may use a portion of the grant funds for set-aside activities such as providing technical assistance to small water systems, operator certification, and source water protection. The grant period runs from July 1, 2025 to June 30, 2030, with the intended outcome of protecting public health through improved drinking water infrastructure and capacity building for public water systems in the state.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $18.0m | 7/25/25 |